Back to Search
Start Over
Female-specific activation of pregnane X receptor mediates sex difference in fetal hepatotoxicity by prenatal monocrotaline exposure.
Female-specific activation of pregnane X receptor mediates sex difference in fetal hepatotoxicity by prenatal monocrotaline exposure.
- Source :
-
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2020 Nov 01; Vol. 406, pp. 115137. Date of Electronic Publication: 2020 Jul 17. - Publication Year :
- 2020
-
Abstract
- Pyrrolizidine alkaloids (PAs) are a group of hepatic toxicant widely present in plants. Cytochrome P450 (CYP) 3A plays a key role in metabolic activation of PAs to generate electrophilic metabolites, which is the main cause of hepatotoxicity. We have previously demonstrated the sex difference in developmental toxicity and hepatotoxicity in fetal rats exposed to monocrotaline (MCT), a representative toxic PA. The aim of this study was to explore the underlying mechanism. 20 mg·kg <superscript>-1</superscript> ·d <superscript>-1</superscript> MCT was intragastrically given to pregnant Wistar rats from gestation day 9 to 20. CYP3As expression and pregnane X receptor (PXR) activation were specifically enhanced in female fetal liver. After MCT treatment, we also observed a significant increase of CYP3As expression in LO2 cells (high PXR level) or hPXR-transfected HepG2 cells (low PXR level). Employing hPXR and CYP3A4 dual-luciferase reporter gene assay, we confirmed the agonism effect of MCT on PXR-dependent transcriptional activity of CYP3A4. Agonism and antagonism of the androgen receptor (AR) either induced or blocked MCT-induced PXR activation, respectively. This study was the first report identifying that MCT served as PXR agonist to induce CYP3A expression. CYP3A induction may increase self-metabolic activation of MCT and subsequently lead to more severe hepatotoxicity in female fetus. While in male, during the intrauterine period, activated AR by testosterone secretion from developing testes represses MCT-induced PXR activation and CYP3A induction, which may partially protect male fetus from MCT-induced hepatotoxicity.<br />Competing Interests: Declaration of Competing Interest All authors declare that they have no conflict of interest.<br /> (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Cell Line
Female
Fetal Development drug effects
Fetus drug effects
Gene Expression Regulation drug effects
Humans
Liver metabolism
Male
Maternal-Fetal Exchange
Pregnancy
Rats, Wistar
Sex Characteristics
Chemical and Drug Induced Liver Injury embryology
Chemical and Drug Induced Liver Injury genetics
Chemical and Drug Induced Liver Injury metabolism
Cytochrome P-450 CYP3A genetics
Liver drug effects
Monocrotaline toxicity
Pregnane X Receptor metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1096-0333
- Volume :
- 406
- Database :
- MEDLINE
- Journal :
- Toxicology and applied pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 32682830
- Full Text :
- https://doi.org/10.1016/j.taap.2020.115137